News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
335 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19554)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Biotech Bay
Movemeant Foundation and Sweaty Betty Bring 4th Annual ‘We Dare to Bare’ to San Francisco
Movemeant Foundation and Sweaty Betty are bringing the country’s largest body-positive fitness fundraising events, We Dare to Bare, back to San Francisco on Saturday, May 12th.
May 1, 2018
·
5 min read
BioForest
New Study Finds Lupus Is A Leading Cause Of Death Among Young Women
A recent study led by UCLA researchers found that lupus is among the leading causes of death in young women.
May 1, 2018
·
3 min read
Pharm Country
Centers of Psychiatric Excellence (COPE) to Present New Research on Ketamine at The American Psychiatric Association’s Annual Meeting in New York City on May 7
The Centers of Psychiatric Excellence (COPE) is pleased to present new research on the drug ketamine at The American Psychiatric Association’s (APA) Annual Meeting in New York, NY, on Monday, May 7.
May 1, 2018
·
2 min read
Business
Richard Petty Motorsports and World Wide Technology Announce New Partnership
Richard Petty Motorsports and World Wide Technology (WWT) announced an official partnership, naming World Wide Technology the Technology and Analytics Partner of Richard Petty Motorsports (RPM).
May 1, 2018
·
4 min read
BioForest
Home Care Pulse Releases 2018 Home Care Benchmarking Study
Home Care Pulse® is pleased to announce the 9th annual publication of the Home Care Benchmarking Study.
May 1, 2018
·
2 min read
Genetown
Restore Health Announces Results of Program Helping to Reverse Chronic Disease High-Risk Factors in Employer Population
Restore Health™ revealed the results of successful one-year case study at the Employer Healthcare Cost & Quality Congress in Washington D.C.
May 1, 2018
·
3 min read
BioMidwest
Step Up for Hearing Loss at the Colorado Walk4Hearing
The Hearing Loss Association of America (HLAA) invites you to participate in the Colorado Walk4Hearing on Sunday, June 10, 2018 at Clement Park in Littleton.
May 1, 2018
·
2 min read
BioMidwest
Biomedical Depot and Imaging Repair Service Now Available from PartsSource
PartsSource has released the new PartsSource Depot Repair to streamline medical depot repairs for healthcare organizations.
May 1, 2018
·
2 min read
FDA
MRA Hails FDA Approval of the First Targeted Oral Therapy to Reduce Risk of BRAF-Mutated Melanoma Returning After Surgery
The Melanoma Research Alliance (MRA) applauds the U.S. Food & Drug Administration (FDA) approval of Novartis’ dabrafenib (Tafinlar®) + trametinib (Mekinist)® for the adjuvant treatment of patients with BRAF-mutant melanoma.
May 1, 2018
·
3 min read
Pharm Country
As Focus Turns to Population Health, N.J. Hospitals Commit $2.9 Billion to Community Benefit Programs
New Jersey hospitals and health systems have upped their investment in community benefit - reaching $2.9 billion in 2016, according to the 2018 Community Benefit Report issued today by the New Jersey Hospital Association.
May 1, 2018
·
3 min read
Previous
25 of 34
Next